Acadia Pharmaceuticals
0 sources
Financials
0001193125-26-072519Acadia Pharmaceuticals
Summary
Acadia Pharmaceuticals is a business[1]. It ranks in the top 4% of business entities by monthly Wikipedia readership (125 views/month).[2]
Key Facts
- Acadia Pharmaceuticals is in the country of United States[3].
- Acadia Pharmaceuticals is in the country of US[4].
- Acadia Pharmaceuticals's instance of is recorded as business[5].
- Acadia Pharmaceuticals's instance of is recorded as public company[6].
- Acadia Pharmaceuticals's headquarters location is recorded as San Diego[7].
- Acadia Pharmaceuticals's stock exchange is recorded as Nasdaq[8].
- Acadia Pharmaceuticals's industry is recorded as pharmaceutical industry[9].
- 1993 marks the founding of Acadia Pharmaceuticals[10].
- Acadia Pharmaceuticals's official website is recorded as http://www.acadia-pharm.com/[11].
- Acadia Pharmaceuticals's product or material produced is recorded as pimavanserin[12].
- Acadia Pharmaceuticals's legal form is recorded as 8888[13].
Product Details
The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.
GLEIF Golden Copy — Level 1 entity data
-
Legal Entity Identifier (LEI): 529900O3044NO0PEA039[14]
-
Registered legal name: Acadia Pharmaceuticals Inc.[15]
-
Legal jurisdiction: US-DE[16]
-
GLEIF entity category: GENERAL[17]
-
Legal form (ISO 20275 ELF): 8888[18]
-
Other legal form: Corporation[19]
-
Entity status: ACTIVE[20]
-
LEI registration status: LAPSED[21]
-
LEI first registered: 2018-10-19[22]
-
LEI last updated: 2021-07-19[23]
-
LEI next renewal: 2019-10-19[24]
-
Managing LOU: 5299000J2N45DDNE4Y28[25]
-
Registration authority: RA000602[26]
-
Authority entity ID: 2707670[27]
-
Conformity flag: NON_CONFORMING[28]
Body
Founding
1993 marks the founding of Acadia Pharmaceuticals[10].
Operations
Acadia Pharmaceuticals's headquarters location is recorded as San Diego[7].
Industry
Acadia Pharmaceuticals's industry is recorded as pharmaceutical industry[9].
Ownership
Acadia Pharmaceuticals's stock exchange is recorded as Nasdaq[8]. Its product or material produced is recorded as pimavanserin[12].
Why It Matters
Acadia Pharmaceuticals ranks in the top 4% of business entities by monthly Wikipedia readership (125 views/month).[2]